Logo image of TME

TENCENT MUSIC ENTERTAINM-ADR (TME) Stock Fundamental Analysis

USA - NYSE:TME - US88034P1093 - ADR

23.03 USD
+0.1 (+0.44%)
Last: 10/16/2025, 10:12:09 AM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to TME. TME was compared to 79 industry peers in the Entertainment industry. TME has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TME is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, TME could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year TME was profitable.
In the past year TME had a positive cash flow from operations.
Each year in the past 5 years TME has been profitable.
TME had a positive operating cash flow in each of the past 5 years.
TME Yearly Net Income VS EBIT VS OCF VS FCFTME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 11.32%, TME belongs to the top of the industry, outperforming 89.87% of the companies in the same industry.
The Return On Equity of TME (15.09%) is better than 83.54% of its industry peers.
TME has a better Return On Invested Capital (9.71%) than 84.81% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TME is below the industry average of 9.15%.
The 3 year average ROIC (6.52%) for TME is below the current ROIC(9.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.32%
ROE 15.09%
ROIC 9.71%
ROA(3y)6.45%
ROA(5y)5.99%
ROE(3y)8.75%
ROE(5y)8.04%
ROIC(3y)6.52%
ROIC(5y)5.78%
TME Yearly ROA, ROE, ROICTME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

With an excellent Profit Margin value of 33.83%, TME belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of TME has grown nicely.
The Operating Margin of TME (28.23%) is better than 96.20% of its industry peers.
TME's Operating Margin has improved in the last couple of years.
The Gross Margin of TME (43.72%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TME has grown nicely.
Industry RankSector Rank
OM 28.23%
PM (TTM) 33.83%
GM 43.72%
OM growth 3Y43.83%
OM growth 5Y10.87%
PM growth 3Y34.13%
PM growth 5Y8.36%
GM growth 3Y12.05%
GM growth 5Y4.42%
TME Yearly Profit, Operating, Gross MarginsTME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TME is still creating some value.
TME has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TME has been reduced compared to 5 years ago.
The debt/assets ratio for TME has been reduced compared to a year ago.
TME Yearly Shares OutstandingTME Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
TME Yearly Total Debt VS Total AssetsTME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

TME has an Altman-Z score of 8.19. This indicates that TME is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.19, TME belongs to the best of the industry, outperforming 91.14% of the companies in the same industry.
TME has a debt to FCF ratio of 0.69. This is a very positive value and a sign of high solvency as it would only need 0.69 years to pay back of all of its debts.
TME's Debt to FCF ratio of 0.69 is amongst the best of the industry. TME outperforms 84.81% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that TME is not too dependend on debt financing.
TME's Debt to Equity ratio of 0.06 is fine compared to the rest of the industry. TME outperforms 64.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.69
Altman-Z 8.19
ROIC/WACC1.38
WACC7.05%
TME Yearly LT Debt VS Equity VS FCFTME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 2.09 indicates that TME has no problem at all paying its short term obligations.
TME's Current ratio of 2.09 is fine compared to the rest of the industry. TME outperforms 74.68% of its industry peers.
TME has a Quick Ratio of 2.09. This indicates that TME is financially healthy and has no problem in meeting its short term obligations.
TME has a Quick ratio of 2.09. This is in the better half of the industry: TME outperforms 75.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
TME Yearly Current Assets VS Current LiabilitesTME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

7

3. Growth

3.1 Past

TME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.73%, which is quite impressive.
The Earnings Per Share has been growing by 10.88% on average over the past years. This is quite good.
Looking at the last year, TME shows a quite strong growth in Revenue. The Revenue has grown by 10.52% in the last year.
TME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.23% yearly.
EPS 1Y (TTM)35.73%
EPS 3Y25.91%
EPS 5Y10.88%
EPS Q2Q%39.5%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y-3.13%
Revenue growth 5Y2.23%
Sales Q2Q%17.91%

3.2 Future

The Earnings Per Share is expected to grow by 17.09% on average over the next years. This is quite good.
The Revenue is expected to grow by 15.27% on average over the next years. This is quite good.
EPS Next Y18.01%
EPS Next 2Y18.3%
EPS Next 3Y17.39%
EPS Next 5Y17.09%
Revenue Next Year14.32%
Revenue Next 2Y14.28%
Revenue Next 3Y13.42%
Revenue Next 5Y15.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TME Yearly Revenue VS EstimatesTME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20B 40B 60B
TME Yearly EPS VS EstimatesTME Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.15, which means the current valuation is very expensive for TME.
Compared to the rest of the industry, the Price/Earnings ratio of TME indicates a somewhat cheap valuation: TME is cheaper than 77.22% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.53. TME is around the same levels.
A Price/Forward Earnings ratio of 23.89 indicates a rather expensive valuation of TME.
77.22% of the companies in the same industry are more expensive than TME, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.04. TME is around the same levels.
Industry RankSector Rank
PE 29.15
Fwd PE 23.89
TME Price Earnings VS Forward Price EarningsTME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

TME's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, TME is valued a bit cheaper than 75.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.73
EV/EBITDA 22.75
TME Per share dataTME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

TME's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
TME has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as TME's earnings are expected to grow with 17.39% in the coming years.
PEG (NY)1.62
PEG (5Y)2.68
EPS Next 2Y18.3%
EPS Next 3Y17.39%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.31%, TME has a reasonable but not impressive dividend return.
TME's Dividend Yield is rather good when compared to the industry average which is at 27.49. TME pays more dividend than 88.61% of the companies in the same industry.
With a Dividend Yield of 1.31, TME pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

TME does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
TME Yearly Dividends per shareTME Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y18.3%
EPS Next 3Y17.39%
TME Yearly Income VS Free CF VS DividendTME Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

TENCENT MUSIC ENTERTAINM-ADR

NYSE:TME (10/16/2025, 10:12:09 AM)

23.03

+0.1 (+0.44%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners67.61%
Inst Owner Change-0.07%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.49B
Analysts81.18
Price Target28 (21.58%)
Short Float %5.28%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.13
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date04-03 2025-04-03 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.25%
Min EPS beat(2)2.25%
Max EPS beat(2)12.25%
EPS beat(4)3
Avg EPS beat(4)5.56%
Min EPS beat(4)-4.78%
Max EPS beat(4)12.53%
EPS beat(8)7
Avg EPS beat(8)3.76%
EPS beat(12)10
Avg EPS beat(12)5.02%
EPS beat(16)13
Avg EPS beat(16)6.05%
Revenue beat(2)2
Avg Revenue beat(2)2.56%
Min Revenue beat(2)0.15%
Max Revenue beat(2)4.97%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)4.97%
Revenue beat(8)6
Avg Revenue beat(8)1.28%
Revenue beat(12)9
Avg Revenue beat(12)1.13%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)4.67%
PT rev (3m)49.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.48%
EPS NY rev (1m)0.06%
EPS NY rev (3m)4.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.37%
Valuation
Industry RankSector Rank
PE 29.15
Fwd PE 23.89
P/S 8.35
P/FCF 28.73
P/OCF 28.73
P/B 3.73
P/tB 5.48
EV/EBITDA 22.75
EPS(TTM)0.79
EY3.43%
EPS(NY)0.96
Fwd EY4.19%
FCF(TTM)0.8
FCFY3.48%
OCF(TTM)0.8
OCFY3.48%
SpS2.76
BVpS6.18
TBVpS4.2
PEG (NY)1.62
PEG (5Y)2.68
Profitability
Industry RankSector Rank
ROA 11.32%
ROE 15.09%
ROCE 11.56%
ROIC 9.71%
ROICexc 15.37%
ROICexgc 28.71%
OM 28.23%
PM (TTM) 33.83%
GM 43.72%
FCFM 29.08%
ROA(3y)6.45%
ROA(5y)5.99%
ROE(3y)8.75%
ROE(5y)8.04%
ROIC(3y)6.52%
ROIC(5y)5.78%
ROICexc(3y)9.52%
ROICexc(5y)8.88%
ROICexgc(3y)19.59%
ROICexgc(5y)19.68%
ROCE(3y)7.76%
ROCE(5y)6.88%
ROICexcg growth 3Y16.02%
ROICexcg growth 5Y-26.04%
ROICexc growth 3Y28.21%
ROICexc growth 5Y-2.74%
OM growth 3Y43.83%
OM growth 5Y10.87%
PM growth 3Y34.13%
PM growth 5Y8.36%
GM growth 3Y12.05%
GM growth 5Y4.42%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.69
Debt/EBITDA 0.4
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 92.44%
Profit Quality 85.96%
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z 8.19
F-Score5
WACC7.05%
ROIC/WACC1.38
Cap/Depr(3y)104.08%
Cap/Depr(5y)129.71%
Cap/Sales(3y)3.85%
Cap/Sales(5y)4.42%
Profit Quality(3y)146.47%
Profit Quality(5y)125.36%
High Growth Momentum
Growth
EPS 1Y (TTM)35.73%
EPS 3Y25.91%
EPS 5Y10.88%
EPS Q2Q%39.5%
EPS Next Y18.01%
EPS Next 2Y18.3%
EPS Next 3Y17.39%
EPS Next 5Y17.09%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y-3.13%
Revenue growth 5Y2.23%
Sales Q2Q%17.91%
Revenue Next Year14.32%
Revenue Next 2Y14.28%
Revenue Next 3Y13.42%
Revenue Next 5Y15.27%
EBIT growth 1Y43.69%
EBIT growth 3Y39.33%
EBIT growth 5Y13.34%
EBIT Next Year50.31%
EBIT Next 3Y25.28%
EBIT Next 5Y22.78%
FCF growth 1Y14.83%
FCF growth 3Y55.02%
FCF growth 5Y9.34%
OCF growth 1Y14.83%
OCF growth 3Y25.17%
OCF growth 5Y10.63%